OncoMate® 5C Matrix Standard
- 5C Matrix Standard labeled with fluorescein, JOE, TMR-ET, CXR-ET and WEN
- Calibration Standard for use with the OncoMate® MSI Dx Analysis System
- IVD Medical Device
- CE-Marked and available in select European countries; FDA-cleared in the United States
Catalog Number:
Size
Catalog Number: MD3850
The OncoMate® 5C Matrix Standard consists of DNA fragments labeled with five different fluorescent dyes (fluorescein, JOE, TMR-ET, CXR-ET and WEN) in one tube. The spectral calibration is performed according to the instrument manufacturer's instructions. OncoMate® 5C Matrix Standard is used to calibrate capillary electrophoresis instruments prior to running the OncoMate® MSI Dx Analysis System to distinguish fluorescent signals from the specific dyes used in the assay.
Intended Use statement: The OncoMate® 5C Matrix Standard is intended for in vitro diagnostic use as an IVD medical device accessory used with the OncoMate® MSI Dx Analysis System (Cat.# MD3140). The standard is used for spectral calibration of capillary electrophoresis instruments prior to analysis of amplification products generated with the OncoMate® MSI Dx Analysis System. This product is intended for professional use only.
Representative Data
Protocols
Complete Protocol
Specifications
Catalog Number:
What's in the box?
| Item | Part # | Size |
|---|---|---|
Matrix Dilution Buffer |
MD191A | 5 × 200μl |
5C Matrix Mix |
MD430A | 1 × 150μl |
SDS
Search for SDSCertificate of Analysis
Use Restrictions
For In Vitro Diagnostic Use. This product is only available in certain countries.Storage Conditions
U.S. Pat. No. 9,139,868, European Pat. No. 2972229, Japanese Pat. No. 6367307 and other patents pending.
Resources
No related resources available
Related Products
No related products available
The OncoMate® 5C Matrix Standard (Cat.# MD3850) is available in the following countries: Austria, Belgium, Czech Republic, Denmark, France, Germany, Hungary, Ireland, Italy, Luxembourg, Netherlands, Norway, Poland, Romania, Slovakia, Spain, Sweden, Switzerland and the United Kingdom. For information about availability in other regions, including the FDA-cleared product in the United States, please contact us.
